Illumina plunges after Q1 revenue outlook trails estimates
April 19, 2016 at 13:47 PM EDT
Shares of Illumina, which provides solutions for genetic analysis, are sinking after the company announced preliminary first quarter revenue that fell short of analysts' consensus estimates.
